Covered recipient · General Payments record
NICOLE TOPILOW
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$3,150.11
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $337.73 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $243.93 | 15 |
| Mallinckrodt Hospital Products Inc. | $37.16 | 1 |
| ABBVIE INC. | $22.17 | 1 |
| Sight Sciences, Inc. | $17.80 | 1 |
| Genentech USA, Inc. | $16.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.17 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106232541 | CMS |
| Amgen Inc. | $24.74 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180486 | CMS |
| Amgen Inc. | $21.99 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180542 | CMS |
| Amgen Inc. | $9.55 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180537 | CMS |
| Amgen Inc. | $6.22 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180489 | CMS |
| Amgen Inc. | $8.44 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180494 | CMS |
| Amgen Inc. | $22.68 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180498 | CMS |
| Amgen Inc. | $5.06 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180506 | CMS |
| Amgen Inc. | $20.84 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180502 | CMS |
| Amgen Inc. | $18.99 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180510 | CMS |
| Amgen Inc. | $23.61 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180519 | CMS |
| Amgen Inc. | $14.70 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180514 | CMS |
| Amgen Inc. | $27.37 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180524 | CMS |
| Amgen Inc. | $21.84 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180527 | CMS |
| Amgen Inc. | $4.44 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180530 | CMS |
| Amgen Inc. | $13.46 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180534 | CMS |
| Genentech USA, Inc. | $16.67 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133081600 | CMS |
| Mallinckrodt Hospital Products Inc. | $37.16 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145145729 | CMS |
| Sight Sciences, Inc. | $17.80 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151929493 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.